Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2022 | 02-2022 | 11-2021 | 08-2021 | 05-2021 | |
| Sales | 0 | 0 | 225 | 41 | 0 |
| Cost of Goods | 0 | N/A | 52 | 1 | N/A |
| Gross Profit | 0 | N/A | 173 | 40 | N/A |
| Operating Expenses | 79,048 | 19,397 | 25,547 | 21,678 | 23,740 |
| Operating Income | -79,048 | -19,397 | -25,322 | -21,637 | -23,740 |
| Interest Expense | -15,369 | 9,822 | 7,970 | 21,759 | 42,428 |
| Other Income | -20,442 | -12,066 | -6,785 | -1,941 | 1,166 |
| Pre-tax Income | -84,121 | -41,285 | -40,077 | -45,337 | -65,002 |
| Net Income Continuous | -84,121 | -41,285 | -40,077 | -45,337 | -65,002 |
| Net Income | $-84,121 | $-41,285 | $-40,077 | $-45,337 | $-65,002 |
| EPS Basic Total Ops | -0.12 | -0.06 | -0.06 | -0.07 | -0.10 |
| EPS Basic Continuous Ops | -0.12 | -0.06 | -0.06 | -0.07 | -0.11 |
| EPS Diluted Total Ops | -0.12 | -0.06 | -0.06 | -0.07 | -0.10 |
| EPS Diluted Continuous Ops | -0.12 | -0.06 | -0.06 | -0.07 | -0.11 |
| EBITDA(a) | $-78,331 | $-18,612 | $-24,254 | $-20,381 | $-22,588 |